Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels
- PMID: 6286
- DOI: 10.1016/0014-2999(76)90090-x
Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels
Abstract
In previous reports, methamphetamine was shown to depress tyrosine hydroxylase (TH) activity in the rat corpus striatum. To evaluate further the mechanism of this decrease in TH activity, enzyme activity was measured in the rat corpus striatum and substantia nigra after repetitive and single-dose methamphetamine administration. Following repeated doses of methamphetamine, nigral TH activity decreased and reached 45% of controls at 12 hr and returned to normal at 60 hr. Striatal TH activity decreased to 40% of control at 36 hr and returned toward normal at 60 hr. When methamphetamine was administered every 6 hr for 30 hr and then discontinued, nigral TH activity returned toward control levels 4 days prior to recovery of striatal TH activity. Methamphetamine initially increased striatal dopamine levels at 6 hr (170% of control). Dopamine levels then decreased in parallel with striatal TH activity but failed to increase as the enzyme recovered. Concurrent administration of chlorpromazine with methamphetamine prevented the methamphetamine-induced decrease in nigral and striatal TH activity and striatal dopamine levels. The results indicate that the methamphetamine-induced depression of striatal and nigral TH activity may be related to increased stimulation of dopamine receptors in the striatum.
Similar articles
-
Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity.Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(2):185-7. doi: 10.1007/BF00500283. Naunyn Schmiedebergs Arch Pharmacol. 1979. PMID: 43481
-
The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.J Pharmacol Exp Ther. 1992 Feb;260(2):817-24. J Pharmacol Exp Ther. 1992. PMID: 1346646
-
Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.J Neurochem. 2016 Feb;136(3):510-25. doi: 10.1111/jnc.13391. Epub 2015 Dec 10. J Neurochem. 2016. PMID: 26465779 Free PMC article.
-
Characterization of dopaminergic influence on striatal-nigral neurotensin systems.Brain Res. 1987 Sep 29;422(1):200-3. doi: 10.1016/0006-8993(87)90560-9. Brain Res. 1987. PMID: 3119151
-
Effects of neuroleptics on striatal dopamine synthesized from 14C-tyrosine.Pharmacol Ther B. 1976;2(1):49-63. doi: 10.1016/0306-039x(76)90018-0. Pharmacol Ther B. 1976. PMID: 772722 Review. No abstract available.
Cited by
-
Glial reactivity in resistance to methamphetamine-induced neurotoxicity.J Neurochem. 2013 May;125(4):566-74. doi: 10.1111/jnc.12201. Epub 2013 Mar 17. J Neurochem. 2013. PMID: 23414433 Free PMC article.
-
Congenital abnormality effect of methamphetamine on histological, cellular and chromosomal defects in fetal mice.Iran J Reprod Med. 2013 Jan;11(1):39-46. Iran J Reprod Med. 2013. PMID: 24639691 Free PMC article.
-
Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.J Neural Transm (Vienna). 1996;103(8-9):987-1041. doi: 10.1007/BF01291788. J Neural Transm (Vienna). 1996. PMID: 9013391 Review.
-
Differential regional effects of methamphetamine on dopamine transport.Eur J Pharmacol. 2008 Aug 20;590(1-3):105-10. doi: 10.1016/j.ejphar.2008.05.028. Epub 2008 May 28. Eur J Pharmacol. 2008. PMID: 18599036 Free PMC article.
-
Methamphetamine toxicity and messengers of death.Brain Res Rev. 2009 May;60(2):379-407. doi: 10.1016/j.brainresrev.2009.03.002. Epub 2009 Mar 25. Brain Res Rev. 2009. PMID: 19328213 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources